Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

Affiliations

• ¹ Paediatric Haematology-Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. simone.cesaro@aovr.veneto.it.
• ² Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
• ³ IRCCS Ospedale Policlinico San Martino, Genova, Italy.
• ⁴ Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.
• ⁵ Clinical Virology, Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
• ⁶ Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
• ⁷ Department of Paediatric Haematology and Oncology, Jurasz University Hospital, Nicolaus Copernicus University Torun, Collegium Medicum, Bydgoszcz, Poland.
• ⁸ Infectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
• ⁹ Haematology Department, Henri Mondor Hospital, APHP, and University Paris Est-Créteil, Paris, France.
• ¹⁰ Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
• ¹¹ CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
• ¹² Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
• ¹³ Klinik fur Innere Medizin II (Haematologie/Oncologie), Universitatsklinikum Jena, Jena, Germany.
• ¹⁴ Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.
• ¹⁵ Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
• ¹⁶ Haematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
• ¹⁷ Service d'Hematologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, Villejuif, France.
• ¹⁸ Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.
• ¹⁹ Department for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
• ²⁰ Department of Internal Medicine II, University of Würzburg, Würzburg, Germany.
• ²¹ Haematology Department, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
• ²² Department of Haematology, Hospital de la Princesa, Madrid, Spain.
• ²³ Division of Haematology, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.
• ²⁴ Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
• ²⁵ Institute of Haematology, Faculty of Medicine and Surgery, "Sacro Cuore" Catholic University, Rome, Italy.